Parvimonas micra: A Rare Cause of Pleural Empyema With COVID-19 Co-infection.
Autor: | Gumbs S; Department of Surgery, Columbia University College of Physicians and Surgeons, Harlem Hospital Center, New York, USA., Kwentoh I; Department of Medicine, Columbia University College of Physicians and Surgeons, Harlem Hospital Center, New York, USA., Atiku E; Department of Surgery, Columbia University College of Physicians and Surgeons, Harlem Hospital Center, New York, USA., Gikunda W; Department of Surgery, Columbia University College of Physicians and Surgeons, Harlem Hospital Center, New York, USA., Safavi A; Department of Surgery, Columbia University College of Physicians and Surgeons, Harlem Hospital Center, New York, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cureus [Cureus] 2024 Jan 10; Vol. 16 (1), pp. e51998. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2024). |
DOI: | 10.7759/cureus.51998 |
Abstrakt: | Parvimonas micra , an oral anaerobe and a known gastrointestinal microbiota, has also been found to be enriched in mucosal tissues of the colon. Our patient presented with chest pain, productive cough, and hypoxia. He was diagnosed with COVID-19 pneumonia with a suspected superimposed bacterial infection. After the initiation of treatment, the patient developed a right hydropneumothorax/loculated pleural effusion on X-ray. Bedside drainage was done, and cross-sectional imaging showed findings of pleural empyema. Cultures obtained after bedside drainage grew P. micra. The patient underwent right posterolateral open thoracotomy, total lung decortication, wedge resection, pneumonolysis, and mechanical pleurodesis. Antimicrobial therapy was adjusted based on culture sensitivities and infectious disease evaluation. Adequate drainage and source control were achieved, COVID-19 infection was resolved, and the patient was discharged on oral antibiotics. This case report highlights a rare and interesting case of pleural empyema caused by a superimposed bacterial infection with P. micra in a patient with COVID-19 pneumonia. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Gumbs et al.) |
Databáze: | MEDLINE |
Externí odkaz: |